A Clinical Study Used to Estimate Central Venous Pressure Non-invasively Using Occlusion Pressure

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 17
SponsorLe Bonheur Children's Hospital

About this trial

The purpose of this study is to collect different measurements using a method called peripheral venous pressure (PVP). PVP checks the pressure in the veins in the arms or legs. It can give doctors a good idea of how well the heart is working, similar to another method called central venous pressure (CVP), which doctors use in hospitals. In this study, the research team will measure PVP in people aged 0-17. The researcher hopes that this data will help doctors understand how PVP measurements relate to health outcomes, which could lead to better ways to diagnose and treat patients in the future.

The peripheral venous pressure (PVP) device will be used to non-invasively measure the pressure required to stop blood flow in the forearm, which will indirectly measure the PVP in the forearm. This device is composed of a pressure sensor and a Doppler flow detector that will be connected to a research laptop for data collection. This device will be placed on the forearm.

If you agree to be in this study, the study team will monitor the venous flow rate (the amount of blood moving through the veins over a certain period of time) using a Doppler Flow Detector while applying pressure to the vein with a pressure sensor. This will take place on the forearm.

The internal jugular vein will be identified and recorded using ultrasound imaging and Doppler sensor.

The forearm vein will be identified and marked using ultrasound imaging. Pressure will be applied for 15 seconds, and then stopped and repeated 4 times, making five sets of measurements.

The procedure may be repeated in 2-3 additional sessions during the hospital stay, if necessary.

Your participation in this study will last approximately 30 minutes.

This procedure is for research only and will not affect your regular care. This will occur during your child's stay in the PCICU/PICU. No additional study visits will be required.

The following procedures are being performed for research purposes only:

Copying information such as your medical history from your medical record; Obtaining non-invasive peripheral venous pressure measurements.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Admitted to PICU or PCICU

Provided written informed consent

Continuous Central venous pressure monitoring transduced from a standard central venous catheter (not PICC line)

Disqualifiers

Glenn and Fontan Patients

Heterotaxy Syndrome Patients

Inability to consent by guardian/caretaker

Trial population

Pediatric patients admitted to the Pediatric Intensive Care Unit (PICU) or the Pediatric Cardiac Intensive Care Unit (PCICU) at Le Bonheur Children's Hospital.

Trial design

Design model

Case-control

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

30 Participants
are grouped into 2 trial groups
Group A: Pediatric Participants Admitted to the ICU with a Central Venous Catheter
Group B: Variable CVP Subset

Trial outcomes

Primary outcomes

1

Mean absolute error (MAE) between non-invasive estimated central venous pressure (Doppler-coupled occlusion-pressure device) and invasive central venous pressure (central venous catheter)

Unit of Measure: mmHg For each participant, the non-invasive estimated CVP value derived from the Doppler-coupled occlusion-pressure measurement (5 technical replicates per session) will be compared to the simultaneous invasive CVP value obtained from the central venous catheter (standard of care). The primary reportable outcome is the MAE across participants, defined as the mean of the absolute difference between paired estimated and measured CVP values, expressed in mmHg. The pre-specified target is MAE ≤ 2 mmHg, consistent with the sample-size justification (n=25 to achieve 80% power assuming an acceptable margin of error of 2 mmHg, a Type I error rate of 5%, and an expected standard deviation of 4 mmHg from prior literature). Intermediate algorithm inputs including vein-occlusion pressure, initial vein diameter, Doppler-isolated venous waveform characteristics, internal jugular vein Doppler recording, and intrapatient and interpatient variability of device output.

Time frame
At time of single study session, up to 60 minutes

Secondary outcomes

1

Correlation between non-invasive estimated central venous pressure and invasive central venous pressure, adjusted for concurrent physiologic context variables abstracted from the electronic medical record

Unit of Measure: Pearson correlation coefficient (r), unitless, range -1.00 to +1.00 Strength of the linear association between the non-invasive estimated CVP (Doppler-coupled occlusion-pressure device) and simultaneous invasive CVP (central venous catheter). The regression model will adjust for concurrent physiologic context variables abstracted from the EMR at the single study session - collected as standard of care, with no extra research procedures: heart rate, cardiac rhythm, respiratory rate, non-invasive and arterial-line blood pressure (systolic, diastolic, MAP), SpO2, ETCO2, awRR, mixed venous oxygen saturation, stroke volume, cardiac output, and intracardiac chamber pressures. Only readily available EMR parameters will be recorded; no procedures will be added to obtain missing data.

Time frame
At time of single study session, up to 60 minutes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Le Bonheur Children's Hospital

Lead sponsor

The Brett Boyer Foundation

Collaborator

This trial is not recruiting at the moment. You can still explore other options: